Consumer Access to Prescription Drugs Improvement Act of 2002

[AI summary unavailable — showing source text] Consumer Access to Prescription Drugs Improvement Act of 2002 - Amends title XVIII (Medicare) of the Social Security Act to establish the Pharmaceutical Advisory Committee as part of the Medicare Payment Advisory Commission. Directs such Committee to review payment policies for drugs under the Medicare and Medicaid programs and make payment policy recommendations, including considering the effects of direct-to-consumer marketing and the use and barriers to use of generic drugs. Focuses studies and requires guidance on physicians' and patients' understanding of the relative efficacy and effectiveness of drugs and biological products, particularly generic versions. Amends the Federal Food, Drug, and Cosmetic Act to require the deposit into a Drug Reimbursement Fund of revenues earned by a patent holder during a period when a competitor was wrongfully enjoined from marketing a generic version. Sets forth notice and publication requirements for agreements reached by a brand name drug company and a generic drug applicant concerning challenges to a patent certification. Amends the title XVIII (Medicare) of the Social Security Act to include coverage for all oral anticancer drugs, regardl…